Literature DB >> 8455588

Cardiac contractile proteins and autoimmune myocarditis.

T Izumi1, H Hanawa, M Saeki, M Kodama.   

Abstract

Concerning cardiac contractile proteins, antigenicity and myocardiotogenicity were discussed. In normal states, these proteins are immunologically tolerant, and can not provoke any heart-specific disease. Why the proteins can provoke such lethal autoimmune myocarditis has not been completely elucidated. Shortly after cardiac infection or myocardial ischemia, these proteins may work as the antigen for the autoimmune myocarditis. First of all, the role of cardiac myosin has been strongly emphasized. But, the antigen determinants: epitope proteins remain unclear. Either cross-activity to the streptococcal M protein and/or the alpha-helical coiled-coil protein may be an important factor to determine antigenicity. In this autoimmune myocarditis, the roles of T-lymphocyte and cardiac dendritic cell are noticeable. Through further study on the relation between antigen epitope and the infectious agents in the heart; on cardio-cytotoxicity of the T-lymphocyte and on the precise contribution of cardiac dendritic cells, this autoimmune myocarditis will be more clarified.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455588     DOI: 10.1007/bf00926855

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences.

Authors:  E M McNally; R Kraft; M Bravo-Zehnder; D A Taylor; L A Leinwand
Journal:  J Mol Biol       Date:  1989-12-05       Impact factor: 5.469

2.  Myosin: a link between streptococci and heart.

Authors:  K Krisher; M W Cunningham
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

3.  Tropomyosin shares immunologic epitopes with group A streptococcal M proteins.

Authors:  P G Fenderson; V A Fischetti; M W Cunningham
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

4.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

Authors:  B Maisch; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

5.  Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart.

Authors:  M W Cunningham; J M McCormack; L R Talaber; J B Harley; E M Ayoub; R S Muneer; L T Chun; D V Reddy
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

6.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

Authors:  C J Limas; I F Goldenberg; C Limas
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

7.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

8.  Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes.

Authors:  J M Gulizia; M W Cunningham; B M McManus
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.

Authors:  B Maisch; R Trostel-Soeder; E Stechemesser; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Authors:  M W Cunningham; S M Antone; J M Gulizia; B M McManus; V A Fischetti; C J Gauntt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more
  1 in total

1.  Myosin-induced autoimmune myocarditis in BALB/C mice.

Authors:  Z Wang; Y Liao; J Dong; S Li; J Wang; Y Tu
Journal:  J Tongji Med Univ       Date:  1999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.